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Here we discuss, how by applying chemical concepts to biological problems, methods
have been developed to map spatiotemporal regulation of proteins and small-molecule
modulation of proteome signaling responses. We outline why chemical-biology platforms
are ideal for such purposes. We further discuss strengths and weaknesses of
chemical-biology protocols, contrasting them against classical genetic and biochemical
approaches. We make these evaluations based on three parameters: occupancy;
functional information; and spatial restriction. We demonstrate how the specific choice of
chemical reagent and experimental set-up unite to resolve biological problems. Potential
improvements/extensions as well as specific controls that in our opinion are often
overlooked or employed incorrectly are also considered. Finally, we discuss some of
the latest emerging methods to illuminate how chemical-biology innovations provide a
gateway toward information hitherto inaccessible by conventional genetic/biochemical
means. Finally, we also caution against solely relying on chemical-biology strategies and
urge the field to undertake orthogonal validations to ensure robustness of results.
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This article is intended to be a primer for the use of chemical biology. We focus on processes
that are limited kinetically by reactive chemistry or that use reactive short-lived molecules
to perturb and/or monitor individual-protein- or locale-specific function in living systems.
We begin by discussing the need for chemical biology and the underlying design/execution
of chemical-biology experiments, including ways to avoid pitfalls. We subsequently highlight
some of the latest, and what we consider most interesting, chemical-biology approaches and
evaluate their benefits and limitations. These methods are contrasted against classical genetic and
chemical/biochemical techniques.
THE NEED FOR CHEMICAL BIOLOGY: BEYOND GENETICS
AND BIOCHEMISTRY
Chemical biology occupies a niche that is not adequately filled by traditional biological sciences.
Biochemistry/enzymology are suited to understand proteins in isolation, or in lysates. Using these
methods, functions of individual proteins have been divined (Knowles and Albery, 1977), rates
of specific steps of enzyme-catalyzed reactions have been elucidated, and development of tools to
modulate a specific enzymatic process has been established. For instance, inhibition experiments
directly impact physiological studies because inhibitors can downregulate specific enzymatic
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function expediently. Such events can in turn impact cellular
pathways/processes rapidly, without the system being given the
chance to compensate for the signaling changes incurred upon
activity loss (as can occur during genetics experiments, vide
infra). By measuring time-dependent effects, one can observe
how the system responds to loss of the target protein’s function.
Such inhibition studies are of course also directly applicable
to drug design and discovery. Perhaps Daniel Bovet’s award of
the 1957 Nobel Prize for physiology or medicine is the best
example of the use of inhibitors for both academic and industrial
pursuits1. The Nobel Prize in Physiology or Medicine 1957
was awarded to Daniel Bovet “for his discoveries relating to
synthetic compounds that inhibit the action of certain body
substances, and especially their action on the vascular system
and the skeletal muscles.” Inhibitors continue to be used to study
age- or context-specific loss of protein function for comparison to
genetic knockout studies or to better model diseases (Ogasawara
et al., 2018). Of equal importance, since knockout and chemical
inhibition are not necessarily the same in terms of percentage of
loss of function and the effect on global protein function, such
chemical-biology experiments require careful consideration and
data interpretation (Hedstrom, 2017).
Biochemistry/enzymology also are often used to study
robust complexes or individual protein function, such as
by immunoprecipitation, or activity assays. However, these
experiments are typically carried out in lysates or on purified
proteins. Cellular compartmentalization is lost under these
conditions, and several other contextual factors are also
perturbed. Such biochemistry experiments were instrumental
in unraveling many fundamental processes, like the nature of
triplet codons (Matthaei et al., 1962). But in many instances,
the loss of context that occurs upon lysis or upon isolation
incurs artifacts or loss of activity/structure, due to, for example,
incorrect preparation techniques (Darling and Reid, 1979; Wang
et al., 2011), or expression conditions (Osz-Papai et al., 2015).
Furthermore, these assays also require large amounts of protein,
thereby losing track of information on cell-to-cell variation, for
example. Small-molecule bulk-exposure regimens tend to lack
resolution at the sub-cellular and organ/tissue scales, unless
cell-surface behaviors are investigated using cell-impermeable
molecules, or deploying, as we see below, chemical-biological
tricks. It is worth noting that the intracellular concentration
of a small molecule is not necessarily the concentration of the
molecule in the media. Especially for reactive small molecules
(Liu et al., 2019), there is often a concentration gradient across
the cell.
On the other hand, genetic tools have proven powerful
for studying the functions and necessities of genes, pathways,
and specific-protein functions. Such studies can often be
carried out in the subcellular locale or organ/tissue of
choice. High-throughput screening approaches to find specific
genetic associations, that are difficult to identify otherwise,
have been applied to global analysis of protein stability
(Yen et al., 2008), cell-to-cell variation (Livet et al., 2007),
and pathway intersections. Genetics—often guided through
1https://www.nobelprize.org/prizes/medicine/1957/summary/
biochemical/structural studies, random mutation of putatively-
important mutants, or genomic sequencing of selected mutants
showing resistance to an inhibitor, or rescue of a specific
phenotype—offers ways to manipulate steady-state information
flow. Oftentimes, these experiments can be carried out at
the single-cell level. However, genetic techniques often lack
dynamic range and precise temporal control, especially in higher
eukaryotes, in all but a few instances. Thus, new methods were
required to deliver high-resolution information on transient
associations, to enable investigations of rapid gain of function,
to effect localized perturbation, or to zoom-in on the signaling
behavior of individual proteins/pathways.
These questions above have all been tackled to varying success
by chemical biology. Chemical biology offers the ability to
generate reactive chemical signals at will, or modulate chemical
properties of specific proteins at a preordained time, often in
specific locales for a specific duration. In many of the most
pertinent and informative scenarios, chemical-biology methods
offer insight because they can generate “on demand” highly-
reactive small molecules, whose half-lives and diffusion distances
are short (Parvez et al., 2018). Localization or duration control
are often achieved in conjunction with genetically-encodable
elements that can serve as frameworks for biocompatible
processes. Thus, although a simplification, chemical biology
exists to some extent to: (1) bring the power of in vitro analysis
to the cell, and ideally to the whole organism; and to (2) extend
genetically-encodable functions beyond those accessible through
the use of canonical amino acids. Indeed, much of the advances
of chemical biology have been made by researchers that seek to
performwork on questions at a “triple point,” i.e., the intersection
of multiple fields, such as chemistry, enzymology, and cell
signaling; or enzymology, bioinorganic chemistry, and genetics.
As chemical biology straddles several spheres of life sciences,
we begin by discussing some intrinsic issues with chemical
biology, and how they can be limited. We further discuss
pitfalls and how to surmount them and aspects of good
experimental design.
UTILITY TO MODEL ORGANISMS
One key benefit of genetic methods/analysis is applicability
to model organisms and humans (e.g., through heredity
maps, lineage information). Indeed, simply examining if a
mutant or disease is dominant vs. recessive, and other simple
hereditary patterns, can give clues to disease mechanisms that
are informative (Wilkie, 1994). Most enzymology/biochemistry
techniques are less applicable to model-organism studies.
Ultimately many inhibitors/small-molecule-probes are either too
toxic, metabolically unstable, or administered in cell/tissue-
penetrable “prodrug” forms, yielding limited information to link
a precise chemotype/target-engagement to phenotype. Of course,
there are some excellent small-molecule modulators/probes
applicable to numerous model organisms. Indeed, 92% of
approved drugs targeting the human proteome are small
molecule-derived as opposed to biologics (Santos et al., 2017).
Ideal chemical-biology methods should be applicable to model
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organisms; however, at the moment, few are generally applicable
to much beyond cell culture. This limitation is in part
because many methods require non-biocompatible chemical
manipulations and/or use reagents either too toxic and/or
impermeable to live models on the order of the experiment,
thereby limiting the experiments to cultured cells or isolated
organelles. Studies in lysates also remain a go-to strategy in proof-
of-concept chemical-biology methods development, although
these conditions provide little or no information on subcellular
regulation or reflect close-to “real-world” conditions with respect
to intracellular concentrations/assemblies/activities of specific
macromolecules or metabolites. It is our hope that more model
organism-based investigations with precise control in space,
time, and context will surface in the future.
DEFINING ON-TARGET SPECIFICITY:
NECESSITATING
ORTHOGONAL VALIDATIONS
Generally, a small molecule used for chemical biology should
be as non-invasive as possible. Thus, it should not ideally cause
cell death, cell-cycle stall, or adversely affect relevant pathways.
Thus, changes in the aforementioned parameters induced by
the small molecule should all be assessed. Such assessments
should be made early in methods development. Since most
cells in culture are grown in high-serum media, ideally the
compound should not interact strongly with serum. Should
serum be an issue, low-serum media is available, or cells can be
switched to serum-free conditions during compound exposure.
Ideally, in model organisms, the molecule should also not
affect growth, development, or fecundity, among other easily-
measurable parameters. Should a molecule/regimen satisfy the
above criteria, one can consider it biocompatible. However, it
should be noted that most genes are in excess and are not
absolutely required for growth/survival, especially in the rich
conditions that we culture cells and organisms. These rich
conditions may mask negative effects that could be observed
under the intended experimental conditions, or when other
stresses are added to the system. This is an ongoing issue for
all research that is not easily addressable. We will elaborate on
some ways chemical biologists have practically obviated these
issues below.
Based on our current understanding of the number of
proteins, protein-modified states, and protein-protein/protein–
nucleic acid interactions, as well as the sheer number of
non-protein molecules in cells, it seems highly unlikely
that any molecule is “100% selective.” Thus, there should
always be concerns levied regarding off-target or artefactual
effects arising due to use of small molecules, regardless of
methods used to evaluate binding promiscuity 1962; Feldwisch-
Drentrup, 2017. How binding promiscuity could impact
a chemical-biology process depends on what the intended
measurements are. Furthermore, observation of binding/labeling
alone does not necessitate changes in enzyme activity/protein
function, protein—protein/nucleic-acid interactions, or any
process relevant to the intended experiment. Since the scope of
this review does not warrant an extended discussion on IDing
small-molecule targets, we focus here on methods aimed at
assessing to what extent a specific output measured following a
small-molecule treatment can be ascribed to a specific protein
under study.
Integrating siRNA/shRNA-Knockdowns to
Small-Molecule Experiments
One of the most common ways to use small molecules for
mechanistic analysis is to assess whether a specific protein’s
activity is required for a process. Proteasome inhibitors are, for
instance, commonly used to investigate degradation mechanisms
(Goldberg, 2012). When using small-molecule inhibitors that
are well characterized to validate if the activity of protein of
interest (POI) or pathway is required for a specific function,
it is responsible to assay more than one inhibitor targeting
the POI or pathway (Zhang et al., 2013; Coffey et al., 2016;
Conciatori et al., 2018; Smith et al., 2019) (Figure 1A). The
use of inactive structural/regioisomeric analogs of a single
inhibitor to verify “on-target” effects is inadequate, since if a
modification manifested within the analog silences an on-target
binding event, it may also silence off-target binding events, or
affect permeation/stability, and overall negative data could be
misinterpreted as “proving” on-target specificity (Figure 1B).
However, in cases where there is high enantiospecificity shown by
a chiral ligand, inactive epimers of the inhibitor that are inactive
are useful (Bondeson et al., 2015).
An alternative way to validate inhibition assays is siRNA,
or knockout technologies. Knockdown/knockout and inhibition
are not necessarily identical to small molecules in terms of
overall effect (Weiss et al., 2007). However, if the POI’s
chemical activity is required for a specific process, the effects
of knockdown/knockout and inhibition should often be similar.
To rule out off-target effects of the siRNA, at least two siRNAs
are best deployed, separately per experiment. If all conditions,
or the majority of conditions, agree with the postulate, this is
good evidence that the POI is involved in the pathway. The
logic of such experiments runs that the off-target binding of
structurally-dissimilar inhibitors, or sequence-dissimilar siRNAs,
is unlikely to converge at a point other than the desired target.
As the number of different components of the comparison, and
indeed the chemical difference across the different comparisons,
increases, the robustness of such a conclusion also increases.
Finally, we note that cell-line validation is critical for genetic
processes. This process must include both antibody validation
and functional validation of knockdown, but may need to
be extended to genotyping genes of interest, especially in
cultured cells (Long et al., 2017a). Rigorous literature searches
are also helpful to uncover other known issues surrounding
generated/evolved lines (Princiotta et al., 2001), or species-
specific effects (Gupta et al., 1986) that can potentially cause
confounding results.
Integrating Resistant Cell Lines
If the mode of action of a compound is unknown, target-
specificity validations are not as simple. One classic method to
assess on-target effects of toxic drugs is to develop resistant cell
Frontiers in Chemistry | www.frontiersin.org 3 March 2019 | Volume 7 | Article 125
Long et al. Application of Chemical Biology in Biological Mapping
FIGURE 1 | Complementary genetic methods to validate chemical biology outcomes. (A) Deconvolution of mammalian target of rapamycin complex (mTORC)-1
and-2 signaling pathways using mTORC-1 selective small-molecule inhibitors, dual inhibitors of mTORC-1 and-2, and specific knockdown of the respective
companion (Raptor or Rictor) of each mTORC (Conciatori et al., 2018). (B) Orthogonal validations to confirm on-target specificity of small-molecule probes/inhibitors.
(1) siRNA/shRNA knockdown (KD), (2) targeted knockout (KO) through CRISPR/Cas9 or other gene-editing techniques, and (3) genotyping in resistant cell lines. In (1),
Dicer, a ribonuclease-(RNase)-III converts shRNAs into siRNAs. The cleaved double-stranded RNA is incorporated into the RNA-induced silencing complex (RISC) and
the resulting strand complementary to mRNA subsequently inhibits mRNA expression. In (2), mammalian cells are transfected with a plasmid containing desired
(Continued)
Frontiers in Chemistry | www.frontiersin.org 4 March 2019 | Volume 7 | Article 125
Long et al. Application of Chemical Biology in Biological Mapping
FIGURE 1 | sgRNA/Cas-9 combination, which results in the formation of a ribonucleoprotein complex of the Cas9 protein and the sgRNA upon expression. Upon the
complementation between sgRNA and the target sequence, the Cas9 protein undergoes allosteric activation and cleaves the double-stranded DNA. This
double-strand break (DSB) will lead to either non-homologous end joining (not shown, but the most commonly employed strategy to make a genetic knockout) or
homologous recombination with an ectopic DNA repair template containing a deletion sequence (shown in figure). Upon cell colony selection, the desired KO will be
confirmed experimentally. In (3) continued exposure, typically to escalating concentrations of a drug, can lead to selection of resistant cells that may overexpress the
target protein (POI OE), or express drug resistant mutants, amongst other possibilities discussed in the text and elsewhere. Inset: Note that on-target validation using
different analogs of the compounds is non-recommendable (see text). (C) Concept of epistasis exemplified by nuclear RNR-α and ZRANB3 in DNA synthesis. RNR-α,
once inside nucleus, binds to ZRANB3 nuclear protein, displacing ZRANB3’s cognate binding partner, PCNA, in vitro and in cell lysates. But this data alone does not
prove that such a mechanism occurs in an intact cell. Cells deficient of ZRANB3 (i.e., ZRANB3-KD) suppresses DNA-synthesis by ∼30−40%, supporting the previous
data on ZRANB3—PCNA binding-dependent DNA-synthesis (Pathway A). Overexpression (OE) of nuclear RNR-α suppresses DNA-synthesis to a similar extent but
this result does not prove that ZRANB3 is a target of nuclear RNR-α in DNA-synthesis downregulation. By examining how nuclear RNR-α affects DNA-synthesis in
ZRANB3-KD cells, the requirement of ZRANB3 for nuclear-RNR-α-dependent effects on DNA synthesis can be assessed. Indeed, in the absence of ZRANB3,
nuclear-RNR-α-promoted DNA-synthesis suppression is ablated, supporting Pathway B (epistatic regulation via ZRANB3) over Pathway B’(direct downregulation,
independent of ZRANB3), and also indicating that ZRANB3 is only a promoter of DNA synthesis (otherwise, the combination treatment would likely lead to a
synergistic suppression of DNA synthesis). This analysis was also backed up by the fact that expression of RNR-α-binding-defective but otherwise functional
ZRANB3-mutants renders cells resistant to nuclear-RNR-α-driven DNA-synthesis inhibition (Fu et al., 2018).
lines, as these may overexpress the drug target (Figure 1B). Thus,
there are known lines resistant to inhibitors such as hydroxyurea,
MK2206, and methotrexate overexpressing their target protein,
namely, ribonucleotide reductase(RNR)-subunit-β (Eriksson
et al., 1984; Aye et al., 2015), Akt3 (Stottrup et al., 2016), and
dihydrofolate reductase (Schimke, 1988), respectively.
However, it should be noted that there are multiple
mechanisms to effect resistance, aside from direct upregulation
of the target. Examining methotrexate resistance as an example,
beyond target-gene upregulation, upregulation of eﬄux and
altered drug metabolism are common routes to resistance
(Bertino et al., 1996; Ercikan-Abali et al., 1997; van der Heijden
et al., 2007). Indeed, transcription and translation of specific
genes are often responsive to their products inhibition, meaning
that cells actively work to countermand suppression of activity,
and also that protein-upregulation often accompanies small-
molecule inhibition. Thus, assessment of protein expression of
the intended target following inhibition should be routine.
Protein overexpression itself can have unexpected
consequences. An overexpressed protein can achieve
micro-molar concentrations in mammalian cells (Zhao
et al., 2018). Thus, particularly in instances where binding
efficacy is moderate-to-high (a situation that can easily
render concentrations of compound administered similar to,
or significantly lower than, the overexpressed protein), the
overexpressed protein could significantly reduce concentrations
of active compound, sacrificially protecting other important
targets, without it actually ever being a biologically-relevant
target. Furthermore, protein overexpression can rewire signaling
networks such that a drug may no longer be effective due to
hyper-stimulation of a compensatory pathway.
Integrating Functional Mutants
In some instances, overexpression of a resistant mutant—
ideally with kinetic properties similar to that of the wild-type-
protein—can also occur upon drug exposure. For instance, the
discovery of RNR-α(D57N) mutant of the enzyme RNR that
has similar in vitro kinetic activity (Aye and Stubbe, 2011) but
is not inhibited by the native nucleotide dATP was discovered
through such experiments (Ullman et al., 1980; Weinberg et al.,
1981; Caras and Martin, 1988). These mutants can also be
used to evaluate on-target specificity through overexpression, or
better yet, through close-to-endogenous expression (Figure 1B;
Wisitpitthaya et al., 2016). Under these conditions, mass action
effects discussed above are much less likely, rendering the
conclusions more incontestable.
Integrating Epistasis Concepts
Modern approaches toward on-target specificity have focused on
knockdown or knockout of the postulated target. Knockdown
of a target typically sensitizes cells to a drug, because one can
consider that some of the drug’s “work” has been done for it, so
it is easier for the drug to take effect. This sort of sensitization is
most-commonly observed under conditions where there is little
phenotypic output due to the knockdown. In some instances,
knockdown of the protein is so acute that there is essentially a
knockout of protein function. Under these conditions (or with
true knockouts), one may expect there to be essentially no impact
of the drug, as there is no target. This condition is termed epistasis
(Cordell, 2002; Miko, 2008). If the drug functions through
processes not associated with the proposed target, then similar
fold effects will still be seen in the knockdown/knockout line.
This sort of analysis applies equally to protein-based inhibitors
and small molecules.
Our laboratory recently used such arguments to elucidate
the pathway through which nuclear-translocated RNR-subunit-
α suppresses DNA synthesis (Fu et al., 2018; Figure 1C).
Our data showed that RNR-α is able to bind to a nuclear-
localized protein called ZRANB3. We hypothesized that this
interaction may inhibit ZRANB3-function because ZRANB3—
RNR-α interaction also led to disruption of PCNA binding to
ZRANB3, and it is known that the ZRANB3—PCNA complex
plays a role in DNA damage response (Poole and Cortez,
2017). Our data revealed that robust (∼85%) knockdown of
ZRANB3 by three different siRNAs suppressed DNA-synthesis
rate by 30–40% (Fu et al., 2018), showing that ZRANB3
is a promoter (although not necessarily required) for DNA
synthesis, and that in the knockdown states, ZRANB3’s activity
is significantly depleted. Overexpression of RNR-α (which raises
nuclear RNR-α levels, allowing ZRANB3 to bind RNR-α)
also suppressed DNA-synthesis rate. Thus, there were several
possible scenarios: (assuming ZRANB3 were a promoter of DNA
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synthesis and RNR-α inhibits ZRANB3) we would see that
ZRANB3-knockdown cells (that have significantly lost ZRANB3’s
DNA synthesis promoting function) are resistant to RNR-α
overexpression; (assuming ZRANB3 were required for DNA
synthesis and RNR-α inhibits ZRANB3) we would see a large
fold increase in fold suppression of DNA synthesis upon RNR-α
overexpression in the knockdown lines as the minimal ZRANB3
remaining would be overwhelmed by the influx of the inhibitor
RNR-α; (assuming ZRANB3 does not mediate the nuclear-RNR-
α-promoted DNA-synthesis suppression) there would be a drop
in DNA-synthesis rate when RNR-α was overexpressed in the
ZRANB3-knockdown cells of the same fold to what was seen in
the control cells. The first of these outcomes was observed (Fu
et al., 2018), consistent with nuclear-RNR-α acting as an inhibitor
of ZRANB3-function and ZRANB3 being a promoter of DNA
synthesis. We validated these experiments by showing similar
outcomes upon dATP treatment, a situation that causes RNR-
α to translocate into the nucleus. We were also able to derive a
functional point mutant of ZRANB3 (that cannot bind RNR-α
but can promote DNA synthesis), and this mutant was resistant
to RNR-α-overexpression (Fu et al., 2018).
Of course, one must be careful to interpret how knockdown,
and especially knockout, affects cells. For instance, in some cases
even 85% knockdown of the target protein is not sufficient to
observe significant pathway flux change (Lew and Tolan, 2012),
thus it may not be possible to obtain significant sensitization
using siRNA. Furthermore, since knockout of a target protein
should ideally mimic saturating drug behavior, knockout may not
be tolerated. Thus derived knockout lines can suffer from change
of flux through necessary pathways, likely suppressing growth
rates, or selecting for cells with modified survival responses, etc.
Such residual knockout cells can appear resistant, solely because
a few outliers from the population have been selected. However,
the observance of resistance in knockout lines still remains good
evidence for an on-target mechanism (Chauhan et al., 2012).
Accordingly, the use/derivation of resistant point mutants as
performed above are highly useful for mechanistic studies.
DEALING WITH ECTOPIC PROTEINS:
JUDICIOUS CHOICES FOR
MINIMAL INTERFERENCE
Aside from employing ectopic small molecules, many chemical-
biology methods employ unnatural (often fusion) proteins
ectopically expressed in the system under study. The effect of
these non-native elements must be considered when evaluating
each specific method and the data each method produces. Any
perturbation imposed by the ectopic protein on the basal levels
of pathway signal and the responsivity of the pathway must
be assessed.
Transient Expression vs. Stable Integration
Considerations should also be made on how such transgenes will
be introduced (Figure 2A). For cell culture, transient transfection
is common. This procedure tends to give high levels of expression
that are significantly variable across individual cells. Thus, single-
cell analysis must be performed carefully such that expression of
transgene is normalized, or at least accounted for. Furthermore,
bulk phenotypic outputs could be derived from a subset of cells
from the transfected pool (Parvez et al., 2016). Transfection also
requires large amounts of plasmid, and chemical treatment of
cells with lipid or other reagents.
An alternative is the use of cells containing integrated
copies of the plasmid, or integrated ectopic DNA. Integration
can be achieved under conditions of prolonged selection post
transfection (Lin et al., 2015), through viral integration, or
through transposases, all of which typically give “random”
incorporation usually at multiple loci. Targeted integration
(which limits chances of integration incurring off-target effects)
using FLIP-recombinase (Schlake and Bode, 1994; Fu et al.,
2018) or similar setups has also become popular (Figure 2A).
Overall benefits of integration approaches include: obviating the
need to transfect, which gives increased reliability, and reduced
variations across experiments. Furthermore, single clones of lines
can be chosen to ensure uniform expression of the transgene.
If several clones are picked, a range of expressions can be
chosen. Alternatively, inducible lines can be used that give
calibrated expression.
Model organisms vary in their analogies to cell culture in these
respects. Some are routinely manipulated transiently or through
modification at the genome level during experiments. Zebrafish
is a good example of such a system (Figure 2B). Others are
almost exclusively manipulated through heritable manipulations,
such as C. elegans. There are also some species-specific quirks,
such as the ability of worms to form stable extrachromosomal
arrays. We have shown that this system can prove very useful for
chemical biology as the array-containing worms can be selected
using a visual marker (e.g., fluorescence), and give a predictable
percentage of transgenic progeny vs. wildtype progeny (Hall-
Beauvais et al., 2018; Long et al., 2018a). Thus, experiments
ultimately contain both wildtype and transgenic animals derived
from the same founders that have been exposed to identical
experimental conditions.
Knock-Out/Knock-In Lines
There are several issues that need to be considered when planning
to derive knockout or knock-in lines. There are important
differences between implementing these approaches in cancer
cell lines vs. model organisms. Indeed, the aneuploidy of cancer
cells renders knock-in generation difficult to achieve currently.
Some cancer cells lines are “near diploid,” such as HCT116,
which has enabled homozygous and heterozygous knock-ins
to be made by several methods we describe below (Duncan
et al., 2012). The issue of aneuploidy in cancer cell lines could
also potentially contribute to difficulty in generating knockout
lines in cancer cells, although this does not appear to be a
huge factor for CRISPR-Cas9 technologies (Yuen et al., 2017).
Notably, the on- vs. off-target effects of all genetic manipulation
strategies are hotly debated (Gallagher and Haber, 2018; Wang
et al., 2018). These issues in whole organisms can be overcome
by outcrossing, but this issue is not possible to “fix” in
cultured cells.
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FIGURE 2 | Methods to express ectopic protein through introduction of ectopic nucleic acids. (A) Genetic integration of POI in cell lines and transgenic (Tg) mice.
Inset: The recombinases [Cre and Flipase (Flp)] can be used to exchange genomic DNA with plasmid DNA to promote targeted integration of your favorite gene (YFG)
into specific cell lines, or a suitable host. The bacteriophage 8C31 integrase can perform a similar function in mouse. 8C31 enables site-specific integration of the
genes flanking phage attB-sites into the locus of host genome that is pre-engineered with up- and down-stream phage attP-sites. This recombination is irreversible
because the resultant attR-flanked genes in host genome is not recognized by 8C31 integrase. (FP, fluorescence protein; IRES, internal ribosomal entry site, that
enables bicistronic expression of, in this figure, YFG and FP). To create a Tg mouse, a suitable embryonic stem (ES) cell line is prepared, and post integration of
YFG-IRES-FP, colonies that have undergone insertion are selected and subsequently injected into a fertilized cell, giving rise to mosaic progeny that can be further
manipulated. After multiple crossing with wild-type (WT) mice, 25% and 50% of the progeny have homozygous and heterozygous YFG knock-in, respectively (lower
row, arrows in salmon). Alternatively, DNA with homology arms overlapping with the target site of interest can be injected into the pro-nuclei of fertilized embryos, and
post-recombination, targeted-knock-in of the specific allele is created (top row, arrows in purple). (B) Transient expression and stable integration of POI in zebrafish.
The eggs of zebrafish, which undergo external fertilization, can be injected with synthetic mRNA, to give ubiquitous, transient expression of YFG. Alternatively, a
number of other random- or targeted-insertion protocols can be used. In this case, the transposon Tol2 is shown that gives random-integration of YFG—IRES—FP
construct. Depending on the promoter driving the transgene (here, YFP and FP), locale-specific or ubiquitous expression can be achieved. (C) Different methods of
POI expression in cultured cells. (1) Transfection of two plasmids gives a population of cells that express both genes (YFG and FP), with expression levels of each gene
varying widely from cell to cell, with little correlation in the relative expression levels of each gene. (2) Separate genes on single plasmids can give standardized
amounts of each protein, although the ratio of each protein is context-dependent, as transcription, mRNA stability and translation are independent between each
protein (YFG and FP). (3) In IRES-driven bicistronic expression systems, transcription and mRNA stability of each protein are the same, but translation of the two
genes (YFG and FP) can be considerably different. Typically, the protein downstream to IRES is expressed to a lower level than the one upstream to IRES. (4) In
P2A-driven systems, transcription, mRNA stability, and translation are all the same (see text for details). (P designates promoter-binding site in B,C).
In general, targeted genome modification involves
introducing a specific targeted DNA double-stranded break
(DSB), which is then fixed either by homologous recombination
(HR) or through non-homologous end joining (NHEJ). Indeed,
the ability to induce specific DSBs is a critical factor of these
experiments, explaining why targeted nucleases are such “big
news.” DSB can be achieved by expression of a nuclease that
will specifically cut at an intended locus. In the modern era,
DSB is most-readily introduced using CRISPR-Cas9, although
other nucleases, including TALENs (Joung and Sander, 2013),
have been and are still used. If there is no DNA with which to
undergo recombination, the cell can repair the damage through
NHEJ. This is an error-prone method that leads to formation of
an “indel” (insertion/deletion polymorphism). Ideally, the indel
creates a premature stop codon in the protein of interest (POI),
yielding a truncated POI, although clearly frameshifts often also
occur. It is important to appreciate that such systems create a
“non-functional” protein, although typically mRNA-production
still occurs and a gene product is often still generated, which
could retain some bioactivity.
Knock-in is a particularly useful method to study the
consequences of unnatural gene-products. Classic methods
involve injection of linearized ectopic DNA into pro-nuclei
of zygotes, and rely upon spontaneous HR (an error-free
process) to introduce the gene of interest. Often times,
the ectopic DNA contains a selection cassette, which can
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be removed post selection by standard methods. In more
modern approaches, a DSB is induced consequentially with the
introduction of the DNA (either short single-stranded DNA
with short overlapping regions, or longer double-stranded DNA)
to promote recombination. Thus, the ectopic DNA can be
incorporated into the locus of the break more efficiently.
Recently, CRISPR-Cas9 has become a method of choice for
generation of DSBs to assist in generation of knock-in lines (Platt
et al., 2014), in a range of organisms including mice (Singh et al.,
2015), worms (Dickinson and Goldstein, 2016), and parasites
(Cui and Yu, 2016). This requires the expression of Cas9, which
can be achieved through the injection of protein, DNA, or
mRNA. Although numerous factors intrinsic to the protein affect
protein expression (such as protein stability), typically, a knock-
in line is the most likely to lead to a set-up where protein
expression (and protein translational/transcriptional regulation)
are unperturbed compared to wild type. Unfortunately, as
alluded to above, we currently lack the ability to generate knock-
in lines of most cancer cells. Thus, knock-in cell lines are derived
from genetically-engineered organisms, whose cells are harvested
and then adapted into cell lines. This approach can work well,
even if the knock-in is unable to survive to adulthood, as all that
is required are relatively early embryos (Fu et al., 2018).
Cre-Lox has been used to perform context- or stage-specific
manipulation of numerous organisms (Figure 2A), and similar
concepts using CRISPR-Cas9 are also being introduced (Katigbak
et al., 2018). Critically, CRISPR-Cas9 editing can be conducted
in adult mice, under correct conditions. Such strategies are
particularly relevant to knockout/mutation of essential genes and
generation of targeted disease models.
Fluorescent Proteins and Epitope Tags
Regardless of the model system and expression system, ideally,
all non-canonical/ectopic sequences, or protein domains should
be removed from the expressed POI. For instance, it is common
to express ectopic POIs as fusions with fluorescent proteins
(FPs) or other chemically reactive domains, like Halo or SNAP,
etc. Our subsequent discussion focuses on FPs, which are
arguably most commonly used and for which several issues
have been raised. However, protein-specific caveats likely apply
to all ectopic protein domains and to a lesser extend linker
regions and epitope tags. Efforts to assess validity (e.g. activity,
localization, response)/rule out artifacts (unexpected effects on
critical pathways, unexpected growth defects, etc.) in the specific
system of use should always be made. FPs are certainly not bio-
inert (Koelsch et al., 2013; Coumans et al., 2014; Ansari et al.,
2016; Ganini et al., 2017); their use should be restricted where
possible, especially in cell culture, unless, for instance, single live
cell analysis is required. If FPs are required, whenever possible,
fusion of FP to the POI can be circumvented through the use
of separate promoters, plasmids, or, more reliably, through the
use of bicistronic systems, such as IRES, or self-splicing peptides,
like P2A. IRES/P2A also allow relative protein expression to
be assessed across different cells (Jang et al., 1988; Pelletier
and Sonenberg, 1988; Trichas et al., 2008; Figure 2C). It is
important to note that IRES and P2A, are cell-type and organism
dependent in terms of their effectiveness. Furthermore, P2A
gives similar levels of each protein post translation (assuming
each protein has similar stabilities Liu et al., 2017), but IRES
biases expression against the protein downstream of the IRES
(Mizuguchi et al., 2000). These nuances have been judiciously
employed in experimental designs (Wang et al., 2015). The
excitation and emission wavelength of the FP should be chosen
to be as far away from background fluorescence and from any
other photochemistry/redox-chemistry that is being conducted.
Typically, red fluorescence gives better signal to noise.
In model organisms, such as C. elegans and D. melanogaster,
the use of FPs as reporters of transgenicity are common, although
dominant phenotypic markers, such as rol-6 (“roller”) or ro+
(“rough”), are also used (Lockett et al., 1992). These phenotypic
markers tend to be derived from known dominant mutants,
leading to obvious physical deformities, and hence are “hard-
wired,” and as they affect, for instance, motility, they may pose
undesired impacts on physiology. By contrast, for FP’s, the locale
of expression can be defined by the user. One can consider
restricting fluorescence to a small number of cells (e.g., touch
neurons, via the C. elegans promoter Mec7, in worms), or to
cells that are not intended for the specific chemical-biology
experiments (such as pharynx expression, via the C. elegans
promoterMyo2, and gut expression of the key transgene, via the
C. elegans promoter, Ges-1). If it is necessary to mark the specific
transgenic cells with FPs, IRES, or likely better P2A fusions of the
required gene with an FP, are best deployed (Figure 2C).
Furthermore, directing subcellular localization of the FP
to a region that is not intended to be studied can also
be useful, such as fusing the FP to a nuclear-localization
sequence (NLS), if studying cytosolic processes with the specific
POI. Finally, expressing POIs with epitope tags (FLAG, HA,
V5, etc.) is often useful in cell culture for enrichment of
specific proteins, but it is almost essential in model organisms,
especially those for which homology with humans is only
moderate, e.g., C. elegans. If the POI is fused to another
protein-tag, such as Halo-Tag, for which highly-specific, low
cross-reactivity antibodies are available (vide infra), such
antibodies can often substitute. However, the background
labeling of the antibody for the proteome from the species
of interest should be evaluated, prior to design of the fusion
construct, and the requirements of the whole experiment should
be considered.
Additional Considerations
Ideally, activity/function of any fusion-POI expressed should
be compared against the non-fused/non-tagged POI. This
assessment can be done in vitro, or by measuring expected
phenotypes/responses in cells/organisms in which the native
protein has been depleted (by RNAi, or genetic knock out) and
the fusion-POI exogenously supplemented. Knock-in lines are
ideal, especially when the gene in question is essential, although
for most purposes, simultaneous knockdown of a specific gene
and plasmid transfection is operationally similar (provided the
knockdown leads to a measurable effect on the cells that can be
rescued). In cases where simultaneous siRNA knockdown and re-
expression of the modified target POI is performed, the ectopic
POI typically should have a synonymous mutation of the siRNA
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target sequence. The re-expressed protein should be shown to
occur at close to endogenous levels.
Because most chemical-biology approaches are multi-
parameter, and these parameters often interact to make a new
state that is not a simple “sum” of the individual parts, it can
be argued that there is no “ideal” chemical-biology method.
Hence, we emphasize that all chemical-biology approaches
should be validated orthogonally. However, we also stress that
close-to-ideal chemical-biology methods lend themselves to
the development of as careful-and-as-close-to-“real” controls
as possible. For our purposes, this means that assay conditions
can be modulated such that a single variable is changed at
a time (e.g., using a point mutant that does not process the
chemistry/signal-propagation as intended). In fact, when such
controls are available or built into the design, results tend to
transpose well to real-life and any small-molecule-induced
perturbations to the resting state of the cell can usually
be tolerated.
PERTURBATION STRATEGIES:
COMPLEMENTING BIOSENSORS
Most chemical-biology perturbation methods begin with the
system at a “basal state” followed by a rapid jump to a new
state induced by some form of chemical perturbation. The time
taken to reach the new state/or the reactivity of the molecules
generated, is often a key parameter that must be optimized such
that genuine dynamics of cell responses can be measured on their
relevant timescales. Thus, just as in classic kinetics experiments,
the speed of the perturbation must be faster than other ensuing
processes intended to be measured, so that a true readout of the
chronology of the responses is established. In many instances,
chemical-biology perturbations can elicit a shift to a “new state,”
or generate a reactive small molecule in minutes or even seconds.
By contrast, the length of time required to synthesize RNA and
protein, and indeed the half-lives of most proteins are typically
hours (Vogel and Marcotte, 2012; Liu et al., 2016; Mathieson
et al., 2018) in higher eukaryotes, although precise values are
species- and protein-dependent. Indeed, genetic techniques,
like LOX/tet/RNAi/Flip/CRISPR-Cas9, also have a long latency.
Arguably the “fastest-responding” genetically-encodable element
ismodulation of protein degradation (either positive or negative).
The fastest responding of these strategies are mostly chemical
genetic in nature. Such perturbation methods include: SHIELD
(Banaszynski et al., 2006), auxin-initiated decay (Nishimura et al.,
2009), HyT (and derivative stress induction methods) (Neklesa
et al., 2011), Boc3Arg (Shi et al., 2016) and PROTACs (Lai
and Crews, 2017). There are also some systems based on heat-
shock that can be applied to organisms such as yeast (Dohmen
et al., 1994), but one must consider the pleiotropic effects of
temperature on the system in these instances as well. Despite
these methods being considered rapid, 1–3 h is still required to
have a significant effect (assumed to occur around 50% protein
depletion, although much greater degradation than that can be
required Lew and Tolan, 2012), and the slow step is almost
certainly the change in stability of the protein target, not the
engagement of the small molecule with its protein target, or the
thermal unfolding of the protein (further underlining the relative
slowness of biological recognition processes; Shamir et al., 2016).
Recently, photoactivatable cell signaling has also become
common. This overall strategy represents another rapid response
genetic unit. Importantly, this strategy has proven applicable to
multiple different biological problems (Zhang and Cui, 2015),
often (although not always) where oligomerization, dimerization,
or recruitment are required for changes of cellular protein
activity. In many instances, the system is also reversible,
rendering these systems ideal for measuring signal-induced
changes. Another group of rapid genetically-encodable methods
involves chemical-induced dimerization (Stanton et al., 2018),
a strategy that dates back to the earliest years of chemical
biology (Spencer et al., 1993), but has found applications to
modern genetic approaches, such as split-Cas9 (Zetsche et al.,
2015). Using Cas9 as a specific example, intended outputs (e.g.,
transcriptional regulation, gene “deletion” or DNA damage)
occur post Cas9 binding to its target DNA-sequence, meaning
they are inherently controlled by factors with relatively long
latency, such as mRNA stability or recruitment of transcriptional
apparatus. Furthermore, Cas9 target engagement can take hours
(Jones et al., 2017), even in E. coli. Finally, genetically-encodable
sensors: such as the ROS-sensors: HYPER (Belousov et al.,
2006) and roGFP (Meyer and Dick, 2010), the calcium sensor:
m-GECO (Zhao et al., 2011); as well as the fleet of biosensors
for kinase-activity (Mo et al., 2017) or metabolite sensing (Litke
et al., 2016; Tao et al., 2017), are also rapidly-responsive elements,
although these are not perturbation/labeling tools. However, use
of these established visualization/activity-monitoring methods
in conjunction with perturbation strategies—such as inhibition,
integration of dominant-negative or gain-of-function alleles, or
other targeted chemical-biology perturbation approaches that we
outline below—offers a gateway to study cell responsivity and
pathway architecture.
PARAMETERS
In this section, we discuss a few representative chemical-biology
techniques (chosen for illustrative purposes from the much
larger armory of methods these days available to researchers)
in terms of the following parameters: (1) occupancy, i.e.,
whether these techniques are intended to saturate their targets
or label only a subset of available targets based on some
parameter; (2) spatial restriction, i.e., how constrained the
techniques can be to a specific macromolecule, organelle, or
interactome; and (3) functional information, i.e., what can we
learn about the consequences of localization/reactivity/labeling
using the technique. We further discuss the overall invasiveness
of the methods and controls that are built in to the methods
and orthogonal validation of the data. We will also evaluate
how compatible and comparable these methods are with
genetic/biochemical techniques.
Target Saturation Methods to Probe
Protein Localization and Associations
These methods are not strictly direct perturbation methods.
However, they ideally employ reactive small molecules, generated
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on demand to chemically tag a specific set of proteins present in a
chosen locale, or interactome, at a specific time (Table 1). These
tagging processes thus reveal proteins either localized within a
specific region or associating with a specific protein, even if they
are present in low amounts, or if the interactions occur for a short
period of time. Optimal parameters for these methods typically
involve minimizing diffusion distance of the reactive molecule
(Parvez et al., 2018), restricting membrane permeability (Yang
and Hinner, 2015), and controlling the exposure time of the
reactive entity to the native environment (Long et al., 2017c;
Parvez et al., 2018).
APEX
APEX is an extremely useful method to profile protein
localizations and associations. The key to this method is
deployment of an engineered soybean ascorbate peroxidase
protein that creates a reactive biotinylated phenoxyl radical,
which has a short half-life (1ms), giving APEX a labeling range
of around 40 nm (Rhee et al., 2013; Figure 3A). The generation
of this molecule within a defined compartment/region gives high
resolution for assigning localizations and associations, which can
be carried out in a multiplex manner (Cruz-Lopez et al., 2018).
For instance, novel mitochondrial-associating proteins have
been identified using APEX. Recent successes of APEX include
profiling of associations at specific genomic loci (Myers et al.,
2018) (through fusion to a binding-competent but catalytically-
inactive mutant of Cas9, dCas9) and identifying new protein-
protein associations (Xue et al., 2017). APEX has also recently
been applied to RNA immuno-precipitation (Kaewsapsak et al.,
2017). Thus, APEX was one of the most-widely used chemical
biology methods in 2017–2018. Soybean peroxidase, from which
both APEX-based probes are derived, is also known to be
relatively robust to pH and temperature (Henriksen et al., 2001),
although it does require a metallocofactor, and hence activity is
dependent on correct loading of the cofactor, which could be
context dependent.
Because of the short half-life and ectopic nature of the
phenoxyradical (Rhee et al., 2013), APEX is unable to probe,
for instance, downstream signaling. It is noteworthy that APEX
outputs, although internally subject to not much more than
20% variability run to run, are subject to significant variability
dependent upon the comparison used (Markmiller et al., 2018).
Thus, multiple cross comparisons may be required to build
up a complete picture of the interactome. Furthermore, APEX
tends to favor labeling of unfolded proteins (Minde et al.,
2018), so there is certainly the possibility for biased outcomes.
Soybean peroxidase is known to generate spontaneous reactive
oxygen species under certain conditions, and hence APEX could
confer context specific changes to cellular redox levels that are
difficult to address (Kimura and Kawano, 2015). How the ectopic
overexpression of peroxidase may alter signaling/interactome
architectures and redox homeostasis, etc., has not yet been
assessed. Furthermore, APEX requires stimulation with peroxide
(∼1mM) to form the phenoxy radical. This requirement likely
restricts the use of this technique to 2D-cell culture/isolated
organs (Chen et al., 2015), as it is unlikely whole organisms
will take up peroxide equally. Peroxide treatment is only for
a relatively short time (minutes), but even brief pulses of
peroxide can alter signaling pathways, elicit translocation, and
affect protein stability/integrity (Parvez et al., 2018). Many small
molecules can also be inactivated/compromised by peroxide
treatment. APEX has, however, proven to be compatible with
some important methods, including EM (Martell et al., 2017;
Mavlyutov et al., 2017). Control for the peroxide is an intrinsic
challenge of the peroxidase-based platform. The bioactivity of
the phenoxy-radical-precursor that cells are treated with for
significant dose (0.5mM) and exposure-time (0.5 h) prior to
oxidation as well as the post-treatment quenching regimen
(5mM Trolox and 10mM ascorbate performed 3 times), also
remains untested.
BioID
BioID uses an engineered promiscuous E. coli biotin ligase. This
protein generates a reactive biotinylated molecule, biotin-AMP,
in situ (Figure 3B). Biotin-AMP is a type of acyl phosphate,
which are short-lived species whose hydrolysis liberates around
as much energy as ATP hydrolysis (Meyerhof and Shatas, 1952;
Di Sabato and Jencks, 1961). Acylphosphates are kinetically
TABLE 1 | Comparison of the representative chemical-biology techniques discussed in this review.
PROTAC APEX BioID (mini) Turbo ID si/shRNA
knockdowna
T-REX G-REX
Effective time (t1/2) 1–3 h 1min ∼18 h 10 min−2 h Variable (hours to days) 1min 1 min
Occupancy High Proximity-
dependent
Proximity-
dependent
Proximity-
dependent
Time-dependent Target-
dependent
Low
Spatio-temporal
control
Low High Medium Medium Low High n.d.b
POI-specific
functional
information
High Low Low Low Variable (dependent on
target intrinsic stability)
High Low
Organismal
applications
High Low Medium Medium Medium Medium Medium
aRNAi is highly species dependent. It is extremely efficacious in worms, where effects can also be heritable. In higher eukaryotes, RNAi delivery is a significant challenge, although there
are some drugs that have entered trials. Yeast and other lower eukaryotes and prokaryotes lack RNAi machinery.
bNot yet determined.
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FIGURE 3 | Representative proximity-based target ID platforms. (A) APEX method. APEX-fused POI is overexpressed in live cells and targeted to the compartment of
interest, such as the mitochondrial intermembrane in this example. The typical experimental procedure involves incubating cells with biotin-phenol (30min, 0.5mM)
followed by a brief exposure to H2O2 (1min, 1mM) to initiate the biotinylation of the proteins proximal to the POI (within ∼40 nm). After quenching the oxidants, cell
lysis and streptavidin enrichment, the biotinylated proteins can be ID’ed by trypsin-digest and LC-MS/MS analysis. Currently, APEX’s application is limited to 2D-cell
culture and isolated organs. (B) BioID method. In this proximity-biotinylation catalyzed by promiscuous biotin ligases (BLs), various forms of BirA mutants have been
employed, with TurboID and miniTurboID as the latest, leading to biotinylation of proteins spatially close to the POI (fused to BL). These biotin ligases catalyze the
(Continued)
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FIGURE 3 | formation of biotin-5
′
-AMP ester, which diffuses out of the active site and is captured by the accessible nucleophilic residues (primarily lysine) of the POI
and those of the proteins within 10 nm on average from the POI. BioID experiment typically requires 18 h or longer periods of time to achieve significant biotinylation of
the proteins. TurboID and miniTurboID have significantly improved the biotinylation efficiency (10min – 2 h) with little difference in labeling output. TurboID and
miniTurboID have been successfully applied to tissue-specific protein ID using D. melanogaster and C. elegans as model organisms, although the optimized
biotinylation conditions of TurboID and miniTurbo in human cells may not be transposable to these organisms, owing to the differences in growth temperature and
time scale. (C) PUP-IT method. This method IDs protein–protein interactions through proximity-PUPylation on cell surface; e.g., PUP-IT has been applied to mark the
cell–cell recognition events between Raji and Jurkat cells. The FKBP fusion of CD28 is stably expressed on cell-surface membrane in Jurkat cells. Upon addition of
rapamycin (orange oval) and PafA(PUP ligase)-FRB fusion protein to the growth media, a functional PUP-IT complex proximal to CD28 receptor is formed. The
addition of biotin-DE28 (purple triangle)—the truncated PUP protein that remains active in PUPylation reaction catalyzed by PafA—enables PUPylation of Raji
cell-surface proteins CD80 and CD86 rapidly (magenta triangle), which are known to interact with the CD28 receptor in Jurkat cells. Inset shows the underlying
chemistry. FKBP, FK506 binding protein. FRB, FKBP-rapamycin binding domain.
less stable than ATP, although they are more stable than the
phenoxy radical generated by APEX in water (Long et al., 2016).
However, in the biological milieu, biotin-AMP is ephemeral and
has a diffusion distance of around 10 nm (Kim et al., 2014)
(i.e., is likely more spatially restricted than APEX and may
ultimately give protein-level resolution Rees et al., 2015), and
is capable of labeling proximal lysines. One critical difference
between APEX and BioID is that BioID does not require
stimulation with peroxide to generate the intermediate, and
as such BioID has been applied to multiple model organisms
including mice, Toxoplasma gondi (Long et al., 2018b), and
slime molds. Recently, there have been some extensions to this
method to improve the context dependence, including split-
BioID (De Munter et al., 2017; Schopp et al., 2017). Critically,
two different split proteins have been reported, testifying to
the versatility of BioID. Finally, BioID has recently been
coupled with affinity purification MS, using Strep-II tag to allow
more quantitative analysis of interaction distances across large
complexes (Liu et al., 2018b).
One of the major issues with BioID is the slow kinetics
of formation of biotin-AMP, which can particularly restrict
use in organisms that are not grown at 37◦C. This issue was
recently overcome by engineering ligases with heightened kinetic
proficiencies. TurboID and miniTurbo (a truncated version of
TurboID) allow substantial biotinylation of the proteome in a
few hours, as opposed to the typical 18 h in BioID (Branon et al.,
2018). Although, little difference in the labeled proteins detected
was observed between the two conditions in cultured cells,
several important applications were shown in model organisms.
For instance, the embryonic development of C. elegans is
approximately 14 h and its optimal development temperature is
16–20◦C (Zhang et al., 2015). Thus, a rapid labeling strategy
is required to enable sufficient build-up of labeled protein in
the embryonic stages. As may have been predicted, BioID did
not label embryos well, but TurboID and miniTurbo yielded
robust labeling.
BioID requires ATP to generate the reactive species. Thus,
one could consider BioID to be more cellular context-dependent
than APEX. Although this question has not been systematically
addressed, and despite ATP being a critical component of the cell,
it is known that ATP levels are fluxional (Imamura et al., 2009;
Tantama et al., 2013) and time-(Schneider and Gourse, 2004)
and locale-dependent (Suzuki et al., 2015) and variable cell-to-
cell (Yaginuma et al., 2014). Furthermore, although many of the
issues of BioID were solved by Turbo/miniTurbo-ID, it is worth
noting that these proteins are not inert and can potentially stress
cells/deplete cellular resources. Evidence for this was provided
as TurboID-expressing worms were developmentally delayed,
although this was not observed in miniTurboID-expressing
worms; the reasons for these differences are unknown. It is
possible that split TurboID would obviate some of these issues.
Reactive Ubiquitin Analogs
Another recent innovation aimed at mapping the cellular
interactome exploits the enzymatic formation of acylphosphate
intermediates on ubiquitin-like small protein domains, namely,
prokaryotic ubiquitin-like protein (PUP) (Pearce et al., 2008)
and Nedd8 in eukaryotes (Kamitani et al., 1997). PUP and
Nedd8, upon activation by specific enzymes, PafA and Ubc12,
respectively, form acylphosphates. By fusing proteins capable
of forming PUP-acylphosphate or Nedd8-acylphosphate to
a POI, proteins that associate with the POI have been
identified. Since Nedd8 is an endogenous modification process
in cultured mammalian cells, evaluation of the specificity of
the tagging process is more complex than PUP. Furthermore,
it remains unknown how elevated Nedd8-modification of
individual proteins may impinge on native signaling/protein-
association networks.
An extension to the Nedd8 approach has also been applied to
identification of ligand—protein interactions. In this case, SNAP
tag, an epitope tag that reacts irreversibly with a benzyl guanidine
(Hill et al., 2016), was fused to an engineered Nedd8-conjugating
enzyme Ubc12 that is capable of conjugating a biotinylated
Nedd8 to proximal proteins. When a benzyl guanidine tag was
fused to a small molecule of interest, such as Dasatinib, a
Bcr-Abl/Src kinase inhibitor, known binders of Dasatinib were
modified by Nedd8.
The PUP-based method can identify interactions that are very
low affinity in vitro (maximumKd ∼ 250µM). Cell-based studies
focused on the interactome of membrane proteins including
CD28 (Liu et al., 2018a). Critically, modification by PUP was
exclusively at lysine. Furthermore, several new interactions were
identified, and these interactors were dependent on the presence
of the CD28 C-terminal tail (Figure 3C). The experiments were
carried out over a period of 24–36 h, timescale to similar to those
used in Bio-ID.
The PUP/Nedd8 methods have strengths and weaknesses
similar to Bio-ID as the intermediate formed is an acylphosphate
(similar to the acyl-AMP intermediate Di Sabato and Jencks,
1961) and the protein turnover mechanism and kinetics may be
similar. However, it is noteworthy that acylphosphate half-lives
are variable in solution and biological systems (being dependent
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likely on enzymatic and metal-catalyzed hydrolysis, to name
two variables Di Sabato and Jencks, 1961; Parvez et al., 2018).
Thus, careful considerations must be placed on the cellular
backgrounds used when comparing the half-lives/diffusion
distances of these systems. Although a similar concern applies to
phenoxy radicals, such as are generated by APEX, the interaction
preferences andmodes of interaction/destabilization are different
between acyl phosphates and radicals (Parvez et al., 2018). Thus,
factors affecting longevity, diffusivity and off-target interactions
are likely different between the methods. Interestingly, although
both Bio-ID and PafA are ATP-hydrolyzing proteins whose
kinetics are readily assessable in vitro, these have not been
quantitatively compared. It has been shown that PafA is more
readily auto PUPylated than BirA is auto-biotinylated (Liu et al.,
2018a), but these outputs could be dependent on multiple
factors not necessarily intrinsically linked to the activities of
the enzymes.
There is also a significant difference in sizes between
Nedd8/PUP and biotin. These differences clearly affect several
biophysical aspects of the reactive intermediates, including: (1)
the diffusion properties of the two molecules (diffusion distances
decrease rapidly in cells as a function of size Parvez et al., 2018);
(2) how themodified proteinsmay behave, in terms of association
and stability over the long duration required for the experiment;
(3) how the cell is affected; (4) the intrinsic reactivity biases
of each probe; and yet (5) mean that for Nedd8/PUP both the
activating protein AND the substrate’s locale can be controlled to
zero-in on associations/effects in specific locales.
Finally, it is noteworthy that immediately post synthesis,
PafA is able to activate PUP and label interacting proteins.
Maturation of T cells (and T-cell receptors, such as CD28)
is complex (Wucherpfennig et al., 2010), and it is unknown
precisely where upon thismaturation process PUP ismost readily
able to label the CD28 interactome. Almost certainly, PUP is
available at themembrane surface where CD28 ultimately resides,
but it is unknown if PUP is present at points along the CD28
maturation process. Furthermore, because the dwell time of
CD28 is relatively short during its maturation compared to its
final localization (Stoops et al., 2015), and PUP-IT is relatively
slow to label proteins, it is likely some chaperones aremissed even
if PUP were to be available at all points along the maturation
pathway. APEX, with its faster labeling kinetics and small
molecule substrate would likely be able to ID more potential
interacting proteins (especially from locales where CD28 does
not ultimately reside), especially if used in conjunction with
inhibitors. Of course, unlike the small molecule substrate of
APEX, PUP can be specifically targeted to specific locales along
the CD28 maturation pathway. For instance, attempting to ID
CD28 associating proteins using cells expressing ER-localized
PUP, would illuminate “only” ER-specific interactors, provided
PafA and PUP are functional in the ER.
Other Reactive-Molecule-Based Methods
and Extensions
Other reactive-molecule-generation methods have recently been
disclosed that function similarly to those discussed above, such
as reactive N-arylation by N-acyl transferases (Kleinpenning
et al., 2018). Although, so far these new techniques have not
particularly expanded the repertoire of reactive molecule-based
probes, they do have different requirements/cofactors needed for
activity. Thus conditions where deployment of these probes is
more informative than APEX and BioID may thus not yet have
been discovered/assayed. Extensions to APEX and BioID have
focused on trying to extract more data from the labeling reactions
than simple protein ID using BioID and APEX (Udeshi et al.,
2017; Kim et al., 2018). The logic of these extensions goes that
a more detailed idea of the interaction region can be gained using
such strategies. However, in order for such experiments to work
well, the resolution would have to be less than the size of a protein
domain 2–5 nm—a scenario unlikely to be easily achievable based
on reported diffusion distances (Parvez et al., 2018). There would
also have to be assumptions that all residues react equally with
these high-energy probes.
COMPARISON WITH CLASSICAL
METHODS TO UNDERSTAND
LOCALIZATION AND ASSOCIATION
Protein localization is a critical parameter governing protein
function. For instance, many proteins gain new associations,
or functions upon translocation leading to important cellular
responses. In some cases, the amount of translocation or
partitioning of a protein between different organelles can be
minimal. For instance, only a 2- to 3-fold increase in nuclear
RNR-α levels can elicit suppression in DNA synthesis (Fu
et al., 2018). Whether such small fold changes could be reliably
detected by APEX localization studies and similar methods, in
our opinion, remains to be conclusively proven.
The question of where proteins localize has been studied
traditionally by immunofluorescence (IF) and fractionation. Both
methods are powerful and often give consistent outcomes. These
methods are ostensibly quantitative and so in principal can give
an idea of relative amounts of protein in one locale over another
and can measure even quite small changes.
However, it is worth remembering that traditional methods
tend to suffer from limited spatial resolution and low sensitivity.
This is for a number of reasons. First, both readouts are typically
made by antibodies, so validating specificity through the use of
clear controls (knockout/siRNA) are important and in reality in
IF and western blotting, background labeling can limit signal to
noise. Both methods suffer from intrinsic artifacts: for IF fixing
can affect protein localization antigen presentation, whereas use
of fluorescent proteins can affect target protein localization;
during fractionation proteins can leak from membranes or there
can be contamination from unintended structures. Thus, in our
opinion at least, perhaps the biggest improvement that reactive
labeling methods bring to localization studies is the ability
to couple an unambiguous readout (MS) to stringent tagging
protocol that is strongly spatially restricted.
There is estimated to be 650,000 protein-protein interactions
(PPIs) in human cells, although this number reflects only a
fraction of a percent of the total number of possible pairwise
interactions (Stumpf et al., 2008). There are likely many more
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possible associations when one considers protein-DNA/protein-
RNA interactions and non-degenerate higher order complexes.
Many of these PPIs are robust, with relatively long half-lives and
Kd’s in the nanomolar range. Such interactions can be readily
assessed by classic methods such as co-IP, native gel, or 2D-PAGE
gels. These methods have benefits in that they can be carried out
in native cells, tissue, etc. However, requirement for lysing of
the cells can introduce artifacts due to dysregulation of cellular
compartmentalization, allowing interactions that do not happen
in the cell to occur (Fu et al., 2018), or loosing weaker interactions
(French et al., 2016). Weaker/more transient associations can be
studied by semi-classical methods such as cross-linking (either
chemical or UV). Crosslinking methods have the benefit of
“trapping” the complex in the cell, prior to lysis, giving more
confidence of cellular relevance, and eliminating the possibility
of post lysis association. However, the use of reactive cross-
linkers also potentially brings in possibilities of off-target cross-
linking, can perturb cellular homeostasis, can mask epitopes, and
may not be compatible with other transformations/experimental
protocols. The reaction products of cross-linking experiments
are also complex aggregates that require extensive verification
and (typically) excellent antibodies that have been rigorously
validated. However, oftentimes protein complexes/aggregates
can be resolved using SDS-PAGE, allowing for identification
of hetero/homo-dimers and/or higher-order aggregates to be
assigned with reasonable accuracy (Aye et al., 2012).
Even though post-lysis associations are minimized by cross
linking, there is little information offered concerning where in
the cell this association occurs. This can be addressed by imaging
experiments. Fluorescence colocalization of FP, or otherwise
tagged proteins, or immunofluorescence has been used to
visualize associations in live cells (Pedley and Benkovic, 2017), as
has FRET (Kenworthy, 2001) and similar methods (Coffey et al.,
2016). The use of proximity ligation (Fredriksson et al., 2002;
Bellucci et al., 2014), which is read out via immunofluorescence
on fixed cells, is also increasing. This method uses DNA-tagged
antibodies that when in “close” proximity (40 nm) can template
a rolling PCR reaction, allowing for puncta to be observed in
specific cellular compartments where an association occurs. This
method is signal amplifying, and hence very sensitive. However,
since the distance covered (40 nm) by this method is much larger
than most proteins, resolution is likely insufficient to “prove” a
“direct” interaction.
There are numerous genetic methods to probe PPIs. The most
commonly investigatedmethod is the yeast-2-hybrid (Y2H) assay
(Vidal and Fields, 2014). This method uses a split transcription
factor one terminus of which is fused to a bait protein, and
the other terminus of which is typically fused to a series of
test proteins. Pairwise combinations of the bait and each test
construct are expressed in yeast. When the bait and a test protein
interact, the split transcription factor is able to form a viable
protein, and typically drives transcription of a gene required for
survival, such that only cells expressing proteins that interact
with the test protein survive. Aside from the requirement to use
ectopic protein and the fact that the native proteins are not used,
criticism has been levied at this method because yeast is not
a similar environment to human cells in terms of complexity,
organelle structure and the posttranslational modifications it
is capable of. Interactions must also happen in the nucleus.
Furthermore, many Y2H methods are based off a 2 micron-
plasmid system (Chan et al., 2013) that gives high expression
of each protein, which “may” provide false positives. However,
false positives are clearly not as detrimental as false negative,
which are also abundant due to incomplete coverage of screening
libraries, incomplete expression and poor folding. The use of
autosomally replicating sequence-containing plasmids can also
alleviate the issue of high protein expression/high copy number
(Newlon and Theis, 1993).
Y2H has been extended to mammalian cells, where more
complex modifications are possible, but many of the same
issues remained, and the library generations are arguably
more complex. Non-allelic non-complementation is a screening
method that looks for unexpected non-complementation (i.e.,
where a cross of two strains with mutations to different genes
do not give viable offspring) and can be carried out in numerous
organisms (Firmenich et al., 1995; Rancourt et al., 1995; Yook
et al., 2001). The likely explanation for such an effect is that
proteins reside in the same pathway, and commonly these
proteins form a complex that is so depleted in the double
heterozygote complementation is not possible. Although this is
clearly an indirect assay, it has proven very informative and
variations of this assay have been used to uncover interesting
aspects of cancer biology (Davoli et al., 2013). Aside from these
in-cell-relevant experiments, phage display has also been used for
HT-protein protein interaction screening (Gibney et al., 2018).
This method is of course sensitive and accurate. However, it lacks
the ability to be employed in cells (Kokoszka and Kay, 2015).
Chemotype Specific Sensing and
Signaling: REX Technologies
REX technologies developed by our laboratory were ultimately
aimed at studying the signaling function of reactive electrophilic
species (RES) in living systems with individual-protein specificity
and in precise space and time (Figure 4) (Fang et al., 2013;
Lin et al., 2015; Parvez et al., 2015, 2016; Long et al.,
2017a,b, 2018a; Hall-Beauvais et al., 2018; Surya et al., 2018;
Zhao et al., 2018). The method uses custom-designed bi-
functional small-molecule probes [such as Ht-PreHNE for
controlled release of a native electrophile 4-hydroxynonenal
(HNE)]. One terminus of the probe binds HaloTag irreversibly
by virtue of a pendant alkylchloride function. The other end
of the bi-functional probe delivers a payload of a specific
reactive electrophilic species, e.g., HNE, upon light illumination
(t1/2 of release for various enals/enone-derived electrophiles,
< 1min) (Lin et al., 2015). Upon RES liberation, sensor
proteins responsive to a given RES have to rapidly intercept
the RES prior to diffusion and/or degradation/metabolism (Liu
et al., 2019). Thus, the concept underlying REX technologies
is unusual in that it harnesses intrinsic “reactivity/affinity-
matching” between the released ligand and (a) POI(s) (Long
and Aye, 2016, 2017; Long et al., 2016, 2017c; Parvez
et al., 2018; Poganik et al., 2018; Liu et al., 2019). HaloTag-
targetable photocaged probes such as Ht-PreHNE (1–20µM)
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are tolerated by cells for > 2 h, and worms/developing fish
for several days (Parvez et al., 2016; Long et al., 2017a,b,
2018a; Hall-Beauvais et al., 2018; Surya et al., 2018; Zhao
et al., 2018). Ht-PreHNE does not affect DNA damage response,
ubiquitination, and several other essential processes in cells and
fish (Parvez et al., 2016; Long et al., 2017a,b; Zhao et al., 2018).
We discuss below two different REX technologies, as well as
potential or yet-unnoticed shortcomings of the method.
T-REX: Target-Specific Reactive Small-Molecule
Sensing and Signaling
T-REX (Figure 4A) uses a HaloTag-POI fusion to give the specific
POI first refusal for the RES (e.g., HNE) photouncaged fromHalo
(Fang et al., 2013; Lin et al., 2015; Parvez et al., 2015, 2016; Long
et al., 2017a,b, 2018a; Hall-Beauvais et al., 2018; Surya et al., 2018;
Zhao et al., 2018). In this way, a specific POI, providing it is
HNE-sensitive, can be HNEylated in the backdrop of a largely
unperturbed cell. T-REX gives relatively high RES-occupancy of
a specific POI, but incurs very little RES-modification/stress of
the total proteome (Parvez et al., 2016; Long et al., 2017a,b; Zhao
et al., 2018). Thus, T-REX is also a highly spatially-restricted
method and has proven to be compatible with numerous other
chemical biology/genetic techniques. Finally, because individual
POIs are modified, functional downstream responses elicited as a
consequence of specific POI—RES interaction can be read out.
Interestingly, proteins that are appreciably modified by HNE
under T-REX tend to undergo phenotypically-dominant effects
as a consequence of substoichiometric-HNEylation (Lin et al.,
2015; Parvez et al., 2015, 2016; Long and Aye, 2017; Long et al.,
2017b; Zhao et al., 2018). Thus, T-REX has established that some
proteins are wired to react rapidly with HNE and to modulate
signaling at fractional occupancy. We have dubbed such proteins
privileged first responders (PFRs) (Long and Aye, 2017; Parvez
et al., 2018; Poganik et al., 2018; Zhao et al., 2018; Liu et al., 2019).
Using T-REX, HNEylation, at individual protein-specific levels,
has been shown to impact numerous critical signaling subsystems
and pathway intersections, including ubiquitination (Zhao et al.,
2018) and phosphorylation (Long et al., 2017b).
The POI-specific nature of T-REX renders the method not
particularly high-throughput. G-REX (vide infra) (Zhao et al.,
2018) can assume this role if it is needed. Critically, because
T-REX uses ectopic expression, RES-labeling and downstream
signaling require the HaloTag protein to be fused to POI; and
expressing the POI and HaloTag separately and replicating T-
REX in this “split” control system ablates both the POI RES-
modification and signal propagation downstream (Lin et al.,
2015; Parvez et al., 2015, 2016; Long et al., 2017b). Similar
controls were recently introduced and shown to be effective
for APEX2 (Ariotti et al., 2015, 2018). We have also identified
point mutants that are enzymatically or functionally active but
do not sense the RES delivered under T-REX conditions (Long
et al., 2017b; Surya et al., 2018; Zhao et al., 2018). Notably, these
mutants are also refractory to downstream signaling changes
induced upon T-REX (Long et al., 2017b; Surya et al., 2018; Zhao
et al., 2018).
T-REX has found application to several model organisms,
such as C. elegans and larval zebrafish (Long et al., 2017b,
2018a; Hall-Beauvais et al., 2018; Zhao et al., 2018). G-REX has
as yet not been so applied. T-REX was used in fish embryos
to study the effects of HNEylation of two different sensor
proteins, Ube2V2 (Poganik et al., 2018; Zhao et al., 2018) and
Akt3 (Long and Aye, 2017; Long et al., 2017b). It was noted
that in these systems, expression of the transgenes was similar
to that of the endogenous proteins (Long et al., 2017b; Zhao
et al., 2018), rendering the systems more “natural” than that in
cultured cells where the level of Halo-POI-overexpression was
significant. Satisfyingly in both cases, delivery and downstream
signaling was observed in zebrafish similarly to cell culture.
However, because of the implicit requirement of UV-light that
is poorly tissue-penetratable, whole organism studies with T-
REX on, for instance, mice or adult fish, are not yet possible.
This current limitation would not restrict use in certain organs
like the brain or blood, however. Two-photon-based photocages
would render REX technologies more broadly compatible and
would also lower the overall impact of the method on UV-
sensitive molecules/processes, such as DNA-synthesis/repair and
RNA regulation.
G-REX: Genome-Wide Assay for Protein Reactivity
With Specific Electrophiles
G-REX (Figure 4B) was established to address limitations
underlying with the existing RES-sensor profiling strategies,
which rely upon high doses of reactive covalent chemicals
for long periods of time. Such flooding strategies tend to
incur significant off-target effects due to mass action. These
approaches, although they likely achieve high occupancy
and modification of multiple potential targets, also affect
physiology through, for instance, perturbing cellular redox
environment, and inducing stress and apoptosis. RES-
permeability, intracellular distribution, metabolism, and
specific subcellular redox environments, etc., altogether render
the consequences of cell treatment by a reactive molecule such as
HNE highly context dependent.
G-REX is designed to release a small, defined pulse of
(alkyne-functionalized) RES [e.g., ∼5µM of HNE over 2–5min
in HEK293T cells with ubiquitous Halo expression (Zhao
et al., 2018)]. Under these controlled conditions, PFRs to HNE
are identified. HNEylated proteins are biotinylated by Click
coupling with azido-biotin, precipitation, resolubilization, and
streptavidin enrichment followed by mass spectrometry. Using
this approach, several PFRs to HNE, including Ube2V2 and
Ube2V1, were identified as well as numerous known HNE
sensors. Importantly, any enriched hits from G-REX can be
validated for HNE-sensing and HNEylation-specific signaling
function using T-REX. By contrast, G-REX is not intended to
study downstream signaling.
UsingG-REX—T-REX coupled strategy, Ube2V2 andUbe2V1
were validated to be HNE-sensitive and modification impact
respective signal propagation downstream (Zhao et al., 2018).
Several biochemical methods further document these findings.
Thus G-REX is an unusual strategy in that it is a global
method that aims to achieve only low-occupancy on-target
proteins (Liu et al., 2019). Its spatial resolution is currently
unknown, although HaloTag itself has been successfully localized
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FIGURE 4 | REX technologies to interrogate precision electrophile signaling (T-REX) and mine kinetically-privileged sensors (KPSs) to specific reactive electrophilic
species (RES) (G-REX). (A) T-REX electrophile delivery. A functional Halo-POI fusion protein is expressed either transiently or stably in live cells, worms, or larval fish.
Treatment of these living models with a bio-inert REX probe [photocaged-RES (with or without alkyne functionalization)] (1–25µM, 1–2.5 h, depending on the system)
results in stoichiometric covalent binding of the probe to Halo. After several rounds of exchange with fresh growth media/buffer containing no probe (to washout the
unbound REX probe), light exposure (1–3min, 365 nm, 0.3–5 mW/cm2, depending on the system) liberates a specific RES of choice (with or without
alkyne-modification) within the microenvironment of Halo-POI, thereby giving the POI the first refusal to the RES. Labeling occurs provided the POI is a KPS of this
RES. Provided the resulting substoichiometric RES-modification of the POI is sufficient to elicit either gain-of-function or dominant-loss-of-function signaling responses,
T-REX presents a unique means to directly link target-engagement to function. [We define such sensors that can elicit dominant responses at low-occupancy as
privileged first responders (PFRs)]. When the alkyne-modified version of the probe is used, the magnitude of measured responses can be quantitatively correlated with
the POI-target-occupancy (by fluorescence-gel-based analysis following Click coupling of the alkyne-functionalized-RES-modified-POI with an azido-fluorophore).
(B) G-REX profiling. G-REX enables genome-wide direct ID of KPSs under controlled and RES-limited conditions. Cells ectopically expressing HaloTag-protein are
treated with the same REX probe used in T-REX (but the alkyne-modified version) under conditions similar to those deployed in T-REX. Without fusing Halo to any
proteins, G-REX approach that allows for user-defined time-, dose-, and locale-controlled release of a specific RES is set to directly capture (localized) native sensors
(i.e., KPSs) most responsive to the liberated RES, at low-occupancy covalent RES-modifications. Cell lysis and click coupling with biotin-azide followed by streptavidin
enrichment engender RES-bound KPS(s) to be ID’ed by digest LC-MS/MS. The resultant top hits can be functionally validated using T-REX (A).
to specific subcellular compartments. It remains unknown how
diffusive/reactive HNE is, which may intrinsically limit this
method’s utility to organelle-specific release.
G-REX has several method-specific limitations. First, G-REX
only releases a brief and low concentration pulse of RES. Thus, G-
REX is a “target-poor” strategy and could potentially miss some
privileged sensors. Such issues can be circumvented by repeating
experiments numerous (3 or more) times and further integrating
quantitative proteomics such as SILAC (Ong et al., 2002) or
TMT-labeling (Thompson et al., 2003). However, MS analysis
is costly and time consuming and these constraints should be
considered when planning/choosing G-REX. To enable target
ID, an alkyne-functionalized variant of native RES is used in G-
REX. For lipid-derived electrophiles (LDEs), alkyne tagging is
minimally (if at all) invasive, although alkynylated versions of
many drugs have been successfully deployed for successful target
ID (Wright and Sieber, 2016; Parker et al., 2017). Radioisotope
tagging or antibody affinity methods present alternatives
to alkyne. However, antibodies are much lower sensitivity
than alkyne-based Click coupling/enrichment, and radioisotope
incorporation may still prove difficult to apply to highly reactive
electrophiles, where there is significant background radioactivity,
especially given the low occupancy of RES-modification that
underlies G-REX. To users’ benefit, biotin/streptavidin-based
enrichment permits the non-alkynylated electrophile to be used
as an “ideal” control for comparison.
VALIDATIONS AND
CURRENT LIMITATIONS
REX-probes currently rely on UV-illumination to liberate RES,
admittedly for a short period of time and at low-power light
sources that the data show does not affect the cell/animal in any
appreciable way (Parvez et al., 2016; Long et al., 2017a,b; Zhao
et al., 2018). Second, REX-platforms require ectopic expression
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of HaloTagged-POI (in T-REX) or HaloTag alone (in G-REX) to
enable localization and concentration of probe (e.g., Ht-PreHNE)
[and liberated RES (e.g., HNE)]. The effects of HaloTag protein
on cellular functions are not clearly known, although HaloTag
has been applied to numerous systems with little negative effects
reported (England et al., 2015).
Notably, identical modification/signaling outcomes are
achieved irrespective of N- vs. C-terminal HaloTagging on the
POI in T-REX (Lin et al., 2015; Parvez et al., 2016). This outcome
indicates that the origin of HNE-liberation is not particularly
relevant to sensing. Thus, it can be inferred that T-REX is
mimicking genuinely what happens post entry of the liberated
RES into the solvent cage of POI fused to Halo. However, we
are still unsure whether solvent cage entry is rate-limiting for
POI-modification, and if reorganizationmay cause unanticipated
issues that affect efficacy of for instance, POI RES-sensing, or
conformational properties of ligand and POI. These concerns
have been partially addressed by assaying in vitro relative rates
of HNEylation of POIs identified to be highly RES-reactive by
T-REX in cells/animals (Long et al., 2017b; Surya et al., 2018;
Zhao et al., 2018). All sensors assayed were found to be uniquely
HNE-sensitive. T-REX assays on POIs identified through G-REX
agree with these conclusions (vide infra).
Third, photocaged probes, such as Ht-PreHNE, may be
subject to inherent biases (intrinsic concern for any small-
molecule probe). Beyond deploying various REX-technical
controls and hypomorphic sensing-defective functional mutants
(Long et al., 2017b; Zhao et al., 2018), the in vitro and other RES
bolus dosing experiments in cells discussed above help assuage
this worry (Surya et al., 2018). Improved photocaging strategies
are presently being undertaken to further limit the possibility
of artifacts.
NON-TETHERED APPROACHES
All the above methods share the unifying theme that a “minor”
perturbation to typical signaling pathways occurs. Critically,
T-REX and G-REX use an ectopic protein anchor to ensure
such a system is maintained as much as possible, i.e., the
Halo protein serves in part to allow washout of excess probe,
ensuring any probe-specific perturbations of the system (due to
the lipid fragment of the probe, for instance) can be removed.
Similar techniques using non-localized/tethered probes have
been applied to mechanistic analysis and target ID, using dual
photocaging (Höglinger et al., 2017). However, in these methods,
the photocaged cannot be completely washed away, due to having
no probe-anchoring device, such as Halo. Organelle specificity
has been instead achieved by chemical means, such as fusing
triphenylphosphine to direct the probe to the mitochondria
(Wagner et al., 2018), and many pioneering contributions have
been made in this arena. The probe concentrations and those of
the released lipids are difficult to normalize under these systems,
and are likely not readily tunable or comparable between different
cells. When using an ectopic protein, as the ectopic protein
expression can be calculated, and the amount of precursor on
the protein can also be assessed, these values are much more
readily normalized. To some extent, the adverse effects of the
excess probe and the uncaged species can be circumvented by
irradiating specific sections of a cell. However, this approach is
restricted to single or a few cell-based analyses.
OUTLOOK
Our aim in this review is 2-fold: to stimulate discussion on
the fundamentals of chemical biology methods; and to highlight
methods development at the boundary of chemistry and biology
with the focus on emerging chemistry-driven perturbation
methods that shed light on the biological locale/interactome
and signaling consequences. It is at this intersection of
biochemical/enzymological and organic chemistry disciplines
where we feel chemical biology is most useful and where as a
field we need to go. Improvement and further expansion should
be built on our better understanding and appreciation of where
the field currently is in terms of limitations that it faces and
successes it has had, on our conscious and responsible use of
methods and understanding of systems to apply them, and on
having a firm idea of where the field is going. We strongly believe
that chemical biology has the ability to deeply probe complex
biological questions but our progress is hampered by reliance on
unrealistic models and analogy to former biochemical studies.
Using the most relevant model systems will be an enabling
step forward in successfully tackling the important problems
unsolvable by traditional genetics and biochemistry.
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